The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

Quality of Life Research

Volumn 5, Issue 1, 1996, Pages 139-150

  Osoba, D ^a,h   Aaronson, N K ^b   Muller, M ^b   Sneeuw, K ^b   Hsu, M A ^c,g   Yung, W K A ^d   Brada, M ^e   Newlands, E ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Integrated Therapeutics Group   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f CHARING CROSS HOSPITAL   (United Kingdom)

^g PFIZER INC   (United States)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Brain cancer; Brain cancer module; Known groups comparisons; Quality of life; Scale reliability

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGED; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; GLIOBLASTOMA; GLIOMA; GREAT BRITAIN; HUMANS; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 0030005978     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00435979     Document Type: Article

References (15)

1. Mackworth N, Fobair P, Prados MD. Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neuro-Oncol 1992; 14: 243-253.
2. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
3. Grant R, Slattery J, Gregor A, et al. Recording neurological impairment in clinical trials of glioma. J Neuro-Oncol 1994; 19: 37-49.
4. Taphoorn MJB, Heinmans JJ, Snoek FJ, et al. Assessment of quality of life in patients treated for low-grade glioma: A preliminary report. J Neurol Neurosurg Psychiat 1992; 55: 372-376.
5. Sachsenheimer W, Piotrowski W, Bimmler T. Quality of life in patients with intracranial rumors on the basis of Karnofsky's performance status. J Neuro-Oncol 1992; 13: 177-181.
6. Archibald YM, Lunn D, Ruttan LA, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 1994; 80: 247-253.
7. Aaronson NK, Bullinger M, Ahmedzai SA. A modular approach to quality-of-life assessment in cancer clinical trials. Rec Results in Cancer Res 1988; 111: 231-247.
8. Osoba D. Self-rating symptom checklists: a simple method for recording and evaluating symptom control in oncology. Cancer Treat Rev 1993; 19(Suppl A): 43-51.
9. Sprangers MAG, Cull A, Bjordal K et al. The European Organization for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 1993; 2: 287-295.
10. Osoba D. The Quality of Life Committee of the Clinical Trials Group of the National Institute of Canada: organization and functions. Qual Life Res 1992; 1: 211-218.
11. Karnofsky DA, Abelman WH, Craves LF et al. The use of nitrogen mustards in palliative treatment of carcinoma. Cancer 1948; 1: 634-656.
12. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. The Barthel Index. Oxford: Oxford University Press, 1987: 49-54.
13. Hays RD, Hayashi T, Carson S, et al. User's guide for the Multitrait Analysis Program (MAP). Santa Monica, CA: Rand Corporation, 1988.
14. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
15. Steel RGD, Torrie JH. Principles and Procedures of Statistics, 2nd ed. New York: McGraw-Hill, 1960.